The new board will assume their positions at the 2019 ISPE Annual Meeting & Expo on Oct. 27–30, 2019 in Las Vegas, NV.
The International Society for Pharmaceutical Engineering (ISPE), a not-for-profit scientific, technical, and regulatory advancement association, announced the results of its 2019–2020 international board of directors election on Sept. 19, 2019. The new board will be responsible for the governance and strategic direction of the ISPE, according to a press release.
The 2019–2020 ISPE international board of directors will consist of:
· Frances M. Zipp, chair, president and CEO, Lachman Consultant Services, Inc.
· Thomas Hartman, vice-chair, vice-president of GMP Operations, Biopharm CMC, GlaxoSmithKline
· Joanne R. Barrick, treasurer, RPh, advisor, global validation support, Eli Lilly and Company
· Jörg Zimmermann, secretary, vice-president, Vetter Development Service, Vetter Pharma Fertigung GmbH&Co KG
· James Breen Jr., past chair, PE, vice-president, project lead biologics expansion, Janssen Pharmaceuticals
· Alice Redmond, PhD, vice-president, European Operations, Commissioning Agents, Inc.
· Scott W. Billman, director global engineering & maintenance, Biogen
· Ylva Ek, chief quality officer, KeyPlants AB
· Lou W. Kennedy, CEO and owner, Nephron Pharmaceuticals
· Stephen C. Mahoney, JD, senior director, global quality & compliance, Genentech, Inc.
· Chris Chen, CEO, WuXi Biologics (Shanghai) Co., Ltd.
· Vivianne J. Arencibia, president, Arencibia Quality Compliance Associates, LLC
· Gunter Baumgartner, vice-president, global engineering, Takeda Pharmaceuticals International AG
· Christine M.V. Moore, PhD, global head and executive director, GRACS CMC-Policy, Merck
· Caroline Rocks, CEng BE MEngSc, senior process engineer, AbbVie, Inc.
· LeAnna Pearson, manager QA validation, BlueBird Bio
The new board will begin their terms at the 2019 ISPE Annual Meeting & Expo on Oct. 27–30, 2019 in Las Vegas, NV.
Source: ISPE
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.